US FDA approves BeiGene’s esophageal cancer therapy

(Reuters) – The U.S. Food and Drug Administration has approved BeiGene’s drug to treat a type of esophageal cancer in patients who have previously received chemotherapy.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)